316 related articles for article (PubMed ID: 19428223)
1. Pharmacokinetic drug interaction between fexofenadine and fluvastatin mediated by organic anion-transporting polypeptides in rats.
Qiang F; Lee BJ; Lee W; Han HK
Eur J Pharm Sci; 2009 Jun; 37(3-4):413-7. PubMed ID: 19428223
[TBL] [Abstract][Full Text] [Related]
2. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides.
Dresser GK; Kim RB; Bailey DG
Clin Pharmacol Ther; 2005 Mar; 77(3):170-7. PubMed ID: 15735611
[TBL] [Abstract][Full Text] [Related]
3. Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction.
Jin MJ; Han HK
J Food Sci; 2010 Apr; 75(3):H93-6. PubMed ID: 20492299
[TBL] [Abstract][Full Text] [Related]
4. Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics.
Yasui-Furukori N; Uno T; Sugawara K; Tateishi T
Clin Pharmacol Ther; 2005 Jan; 77(1):17-23. PubMed ID: 15637527
[TBL] [Abstract][Full Text] [Related]
5. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment.
Olsén L; Ingvast-Larsson C; Larsson P; Broström H; Bondesson U; Sundqvist M; Tjälve H
J Vet Pharmacol Ther; 2006 Apr; 29(2):129-35. PubMed ID: 16515667
[TBL] [Abstract][Full Text] [Related]
6. Effect of fruit juices on the oral bioavailability of fexofenadine in rats.
Kamath AV; Yao M; Zhang Y; Chong S
J Pharm Sci; 2005 Feb; 94(2):233-9. PubMed ID: 15570603
[TBL] [Abstract][Full Text] [Related]
7. Involvement of intestinal uptake transporters in the absorption of azithromycin and clarithromycin in the rat.
Garver E; Hugger ED; Shearn SP; Rao A; Dawson PA; Davis CB; Han C
Drug Metab Dispos; 2008 Dec; 36(12):2492-8. PubMed ID: 18755851
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
Lau YY; Okochi H; Huang Y; Benet LZ
Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
[TBL] [Abstract][Full Text] [Related]
9. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.
Dresser GK; Bailey DG; Leake BF; Schwarz UI; Dawson PA; Freeman DJ; Kim RB
Clin Pharmacol Ther; 2002 Jan; 71(1):11-20. PubMed ID: 11823753
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of fexofenadine following LPS administration to rats.
Jaisue S; Gerber JP; Davey AK
Xenobiotica; 2010 Nov; 40(11):743-50. PubMed ID: 20863200
[TBL] [Abstract][Full Text] [Related]
11. Relative contribution of absorptive and secretory transporters to the intestinal absorption of fexofenadine in rats.
Ujie K; Oda M; Kobayashi M; Saitoh H
Int J Pharm; 2008 Sep; 361(1-2):7-11. PubMed ID: 18572335
[TBL] [Abstract][Full Text] [Related]
12. Development and pharmacology of fluvastatin.
Jokubaitis LA
Br J Clin Pract Suppl; 1996 Jan; 77A():11-5. PubMed ID: 8729584
[TBL] [Abstract][Full Text] [Related]
13. Development and pharmacology of fluvastatin.
Jokubaitis LA
Br J Clin Pract Suppl; 1994 Dec; (77):11-5. PubMed ID: 19489169
[TBL] [Abstract][Full Text] [Related]
14. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine.
Cvetkovic M; Leake B; Fromm MF; Wilkinson GR; Kim RB
Drug Metab Dispos; 1999 Aug; 27(8):866-71. PubMed ID: 10421612
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent interaction between lopinavir/ritonavir and fexofenadine.
van Heeswijk RP; Bourbeau M; Campbell P; Seguin I; Chauhan BM; Foster BC; Cameron DW
J Clin Pharmacol; 2006 Jul; 46(7):758-67. PubMed ID: 16809801
[TBL] [Abstract][Full Text] [Related]
16. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice.
Bailey DG; Dresser GK; Leake BF; Kim RB
Clin Pharmacol Ther; 2007 Apr; 81(4):495-502. PubMed ID: 17301733
[TBL] [Abstract][Full Text] [Related]
17. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism.
Shon JH; Yoon YR; Hong WS; Nguyen PM; Lee SS; Choi YG; Cha IJ; Shin JG
Clin Pharmacol Ther; 2005 Aug; 78(2):191-201. PubMed ID: 16084853
[TBL] [Abstract][Full Text] [Related]
18. Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine.
Tannergren C; Petri N; Knutson L; Hedeland M; Bondesson U; Lennernäs H
Clin Pharmacol Ther; 2003 Nov; 74(5):423-36. PubMed ID: 14586383
[TBL] [Abstract][Full Text] [Related]
19. Alteration of fexofenadine disposition in the rat isolated perfused liver following injection of bacterial lipopolysaccharide.
Tong Y; Zhang R; Ngo SN; Davey AK
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):685-9. PubMed ID: 16895540
[TBL] [Abstract][Full Text] [Related]
20. Intestinal drug transporter expression and the impact of grapefruit juice in humans.
Glaeser H; Bailey DG; Dresser GK; Gregor JC; Schwarz UI; McGrath JS; Jolicoeur E; Lee W; Leake BF; Tirona RG; Kim RB
Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
